[144] Gevo, Inc. SEC Filing

Rhea-AI Filing Summary

On 07/30/2025, GXO Logistics (GXO) director Michael Kneeland received 2,915 Restricted Stock Units (RSUs) under the company’s director equity plan. Each RSU entitles him to either one GXO share or cash equal to its market value upon vesting. The award vests on the earlier of 13-May-2026 or the next annual shareholder meeting, contingent on his continued board service. Following the grant, Kneeland directly owns 3,672 GXO common shares and now holds 2,915 unvested RSUs. No shares were sold, and there was no open-market transaction.

Positive

• Director granted 2,915 RSUs, modestly increasing equity alignment with shareholders.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine director RSU grant; small relative to GXO float; signals continued board alignment, but valuation impact is neutral.

The filing records an equity grant rather than an open-market purchase or sale. The 2,915 RSUs equal less than 0.003% of GXO’s ~120 million share count, so dilution is immaterial. Because RSUs vest within a year, they serve primarily as a retention and alignment tool. There is no indication of insider bullishness beyond standard compensation, nor any concerning disposal of shares. Accordingly, the event is not impactful to the investment thesis.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	32808	41105.00	239562995	08/01/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/26/2025	Restricted Stock Units	Issuer			52755	08/01/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Lynn Smull 345 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	05/30/2025	60331	77344.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did GXO director Michael Kneeland report in the latest Form 4?

A grant of 2,915 Restricted Stock Units on 07/30/2025.

Did Michael Kneeland sell any GXO shares?

No. The filing shows only an RSU grant; no shares were sold.

When do the newly granted GXO RSUs vest?

On May 13, 2026 or the next annual shareholder meeting, whichever comes first.

How many GXO shares does Kneeland now own directly?

He holds 3,672 common shares, plus 2,915 unvested RSUs.

Is this Form 4 likely to affect GXO’s stock price?

The grant is routine and not expected to be material to valuation.